TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 90 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $6,000 | +20.0% | 4,338 | 0.0% | 0.00% | – |
| Q4 2018 | $5,000 | -58.3% | 4,338 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $12,000 | -20.0% | 4,338 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $15,000 | +15.4% | 4,338 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $13,000 | -51.9% | 4,338 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $27,000 | +50.0% | 4,338 | +60.9% | 0.00% | 0.0% |
| Q3 2017 | $18,000 | -5.3% | 2,696 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $19,000 | -24.0% | 2,696 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $25,000 | – | 2,696 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 600,000 | $2,142,000 | 0.14% |
| Tekla Capital Management LLC | 859,322 | $3,068,000 | 0.12% |
| DOW CHEMICAL CO /DE/ | 65,000 | $232,000 | 0.08% |
| Candriam S.C.A. | 495,613 | $1,769,000 | 0.03% |
| A.R.T. Advisors, LLC | 174,335 | $622,000 | 0.02% |
| Baker Brothers Advisors | 935,000 | $3,338,000 | 0.02% |
| FLAGSHIP HARBOR ADVISORS, LLC | 29,400 | $104,000 | 0.02% |
| Alambic Investment Management, L.P. | 17,804 | $64,000 | 0.02% |
| Teton Advisors, Inc. | 44,000 | $157,000 | 0.01% |
| Man Group plc | 737,715 | $2,634,000 | 0.01% |